Sinem Namdaroğlu

489 total citations
30 papers, 252 citations indexed

About

Sinem Namdaroğlu is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Sinem Namdaroğlu has authored 30 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 10 papers in Genetics and 9 papers in Oncology. Recurrent topics in Sinem Namdaroğlu's work include Hematopoietic Stem Cell Transplantation (11 papers), COVID-19 Clinical Research Studies (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Sinem Namdaroğlu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), COVID-19 Clinical Research Studies (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Sinem Namdaroğlu collaborates with scholars based in Türkiye, Cambodia and Antigua and Barbuda. Sinem Namdaroğlu's co-authors include Fevzi Altuntaş, Serdal Korkmaz, Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, Mehmet Ali Erkurt, Abdulkadir Baştürk, İlhami Berber, Burhan Turgut, Tuba Hacıbekiroğlu and Mustafa Mahir Ülgü and has published in prestigious journals such as Blood, Scientific Reports and Journal of Medical Virology.

In The Last Decade

Sinem Namdaroğlu

20 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sinem Namdaroğlu Türkiye 8 137 131 74 31 26 30 252
Tuğçe Nur Yiğenoğlu Türkiye 9 147 1.1× 144 1.1× 73 1.0× 44 1.4× 47 1.8× 65 303
Mehmet Hilmi Doğu Türkiye 10 163 1.2× 142 1.1× 68 0.9× 60 1.9× 58 2.2× 56 345
Adane F. Wogu United States 8 100 0.7× 65 0.5× 51 0.7× 21 0.7× 45 1.7× 18 279
Hagit Padova Israel 7 98 0.7× 229 1.7× 57 0.8× 15 0.5× 12 0.5× 14 366
Erica Brivio Netherlands 8 131 1.0× 60 0.5× 45 0.6× 15 0.5× 11 0.4× 22 254
Francesca Compagno Italy 7 122 0.9× 92 0.7× 24 0.3× 15 0.5× 9 0.3× 15 228
Burton Appel United States 8 125 0.9× 52 0.4× 20 0.3× 74 2.4× 26 1.0× 19 227
Magdalena Corona Spain 6 101 0.7× 117 0.9× 21 0.3× 22 0.7× 10 0.4× 18 182
Naomi Serling‐Boyd United States 7 46 0.3× 188 1.4× 38 0.5× 90 2.9× 12 0.5× 9 287
Thomas Bogue United States 6 80 0.6× 168 1.3× 35 0.5× 99 3.2× 39 1.5× 7 289

Countries citing papers authored by Sinem Namdaroğlu

Since Specialization
Citations

This map shows the geographic impact of Sinem Namdaroğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinem Namdaroğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinem Namdaroğlu more than expected).

Fields of papers citing papers by Sinem Namdaroğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sinem Namdaroğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sinem Namdaroğlu. The network helps show where Sinem Namdaroğlu may publish in the future.

Co-authorship network of co-authors of Sinem Namdaroğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Sinem Namdaroğlu. A scholar is included among the top collaborators of Sinem Namdaroğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sinem Namdaroğlu. Sinem Namdaroğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çalıkoğlu, Emel, et al.. (2025). Telemedicine Service Delivery Model: Usage Areas, Advantages, Challenges and Recommendations – A Modified Delphi Study. Journal of Basic and Clinical Health Sciences. 9(3). 678–686.
2.
Erkurt, Mehmet Ali, İlhami Berber, Sinem Namdaroğlu, et al.. (2024). Efficacy of Ruxolitinib in the management of chronic GVHD. Transfusion and Apheresis Science. 64(1). 104053–104053. 1 indexed citations
3.
Yiğenoğlu, Tuğçe Nur, Sinem Namdaroğlu, Mehmet Ali Erkurt, et al.. (2024). Is there a relationship between vitamin D levels and graft versus host disease?. Transfusion and Apheresis Science. 64(1). 104054–104054.
4.
Namdaroğlu, Sinem, Mehmet Ali Erkurt, İlhami Berber, et al.. (2024). The role of ruxolitinib in the management of acute GVHD. Transfusion and Apheresis Science. 64(1). 104055–104055.
5.
Ulaş, Turgay, Sinem Namdaroğlu, Mehmet Ali Erkurt, et al.. (2024). What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?. Transfusion and Apheresis Science. 64(1). 104058–104058.
6.
Namdaroğlu, Sinem, et al.. (2024). Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting. Journal of Clinical Medicine. 13(17). 5145–5145. 1 indexed citations
7.
Namdaroğlu, Sinem, et al.. (2021). Primary Laryngeal Granulocytic Sarcoma: A Case Report. Indian Journal of Otolaryngology and Head & Neck Surgery. 74(S3). 6075–6077.
8.
Namdaroğlu, Sinem, et al.. (2021). Comparison of Splenectomy and Eltrombopag Treatments in the Second-Line Treatment of Immune Thombocytopenic Purpura. Turkish Journal of Hematology. 38(3). 181–187.
9.
Uğur, Mehmet, et al.. (2021). RETROSPECTIVE EVALUATION OF PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS FOLLOWED IN OUR CLINIC. Hematology Transfusion and Cell Therapy. 43. S51–S52.
10.
Başçı, Semih, Naim Ata, Fevzi Altuntaş, et al.. (2021). Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Internal and Emergency Medicine. 17(1). 135–139. 14 indexed citations
11.
Kaya, Ali, et al.. (2020). Impact of Guideline-Driven Approach in Follow-Up of Long-Term Complications After Allogeneic Hematopoietic Cell Transplant: Single Center Experience. Experimental and Clinical Transplantation. 18(3). 359–367. 2 indexed citations
12.
Altuntaş, Fevzi, Naim Ata, Tuğçe Nur Yiğenoğlu, et al.. (2020). COVID-19 in hematopoietic cell transplant recipients. Bone Marrow Transplantation. 56(4). 952–955. 24 indexed citations
13.
Namdaroğlu, Sinem, et al.. (2019). Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Scientific Reports. 9(1). 2046–2046. 5 indexed citations
14.
Namdaroğlu, Sinem, et al.. (2018). Helicobacter pylori Frequency in Polycythemia Vera Patients without Dyspeptic Complaints. Kocaeli Üniversitesi - AVESİS. 1(1).
15.
16.
17.
Namdaroğlu, Sinem, Serdal Korkmaz, & Fevzi Altuntaş. (2017). Management of mobilization failure in 2017. Transfusion and Apheresis Science. 56(6). 836–844. 13 indexed citations
18.
Kaya, Ali, Emre Tekgündüz, Sinem Namdaroğlu, et al.. (2017). Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?. Transplantation Proceedings. 49(8). 1911–1915. 6 indexed citations
19.
Namdaroğlu, Sinem, Emre Tekgündüz, & Fevzi Altuntaş. (2016). Coexistence of Essential Thrombocythemia, Iron-Refractory Iron Deficiency Anemia and Renal Cell Carcinoma. Hematology Reports. 8(1). 6235–6235. 2 indexed citations
20.
Namdaroğlu, Sinem, et al.. (2013). Microbial contamination of hematopoietic progenitor cell products. Transfusion and Apheresis Science. 48(3). 403–406. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tuğçe Nur Yiğenoğlu Breakdown of academic impact, for papers by Mehmet Hilmi Doğu Breakdown of academic impact, for papers by Adane F. Wogu Breakdown of academic impact, for papers by Hagit Padova Breakdown of academic impact, for papers by Erica Brivio Breakdown of academic impact, for papers by Francesca Compagno Breakdown of academic impact, for papers by Burton Appel Breakdown of academic impact, for papers by Magdalena Corona Breakdown of academic impact, for papers by Naomi Serling‐Boyd Breakdown of academic impact, for papers by Thomas Bogue
Rankless by CCL
2026